Confirmatory Trial Early Planning Is Essential To Address Potential Problems

Sponsors should develop a strategy to address potential challenges to completion of accelerated approval confirmatory studies in advance of conducting the trials, members of FDA's Oncologic Drugs Advisory Committee suggested Nov. 8